{"id":97444,"date":"2025-08-10T00:34:08","date_gmt":"2025-08-10T00:34:08","guid":{"rendered":"https:\/\/pakistaninewspaperlist.com\/news\/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-edgewise-therapeutics-inc-ewtx\/"},"modified":"2025-08-10T00:34:08","modified_gmt":"2025-08-10T00:34:08","slug":"investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-edgewise-therapeutics-inc-ewtx","status":"publish","type":"post","link":"https:\/\/pakistaninewspaperlist.com\/news\/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-edgewise-therapeutics-inc-ewtx\/","title":{"rendered":"INVESTOR ALERT: Pomerantz Law Firm Investigates Claims\u00a0On Behalf of Investors of Edgewise Therapeutics, Inc. – EWTX"},"content":{"rendered":"
\n

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (\u201cEdgewise\u201d or the \u201cCompany\u201d) (NASDAQ: EWTX).\u00a0 Such investors are advised to contact Danielle Peyton at\u00a0newaction@pomlaw.com<\/u><\/a>\u00a0or 646-581-9980, ext.\u00a07980.\u00a0 \u00a0<\/p>\n

The investigation concerns whether Edgewise and certain of its officers and\/or directors have engaged in securities fraud or other unlawful business practices.\u00a0<\/p>\n

[Click here for information about joining the class action]<\/u><\/strong><\/a><\/p>\n

June 26, 2025, Edgewise issued a press release reporting data from clinical trials for its lead asset, sevasemten, against Becker and Duchenne muscular dystrophies.\u00a0 Although Edgewise characterized the results as \u201cpositive,\u201d it also said that the U.S. Food and Drug Administration had \u201cdeemed the CANYON data alone insufficient for an accelerated approval\u201d during a recent Type C meeting.\u00a0<\/p>\n

On this news, Edgewise\u2019s stock price fell $1.27 per share, or 8.86%, to close at $14.33 per share on June 26, 2025.<\/p>\n

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See\u00a0www.pomerantzlaw.com<\/u><\/a>.<\/p>\n

Attorney advertising. \u00a0Prior results do not guarantee similar outcomes.\u00a0<\/p>\n

CONTACT:
<\/strong>Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com<\/a>
<\/a>646-581-9980 ext. 7980<\/p>\n

\n <\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (\u201cEdgewise\u201d or the \u201cCompany\u201d) (NASDAQ: EWTX).\u00a0 Such investors are advised to contact Danielle Peyton at\u00a0newaction@pomlaw.com\u00a0or 646-581-9980, ext.\u00a07980.\u00a0 \u00a0 The investigation concerns whether Edgewise and certain of its officers and\/or directors have engaged in securities […]<\/p>\n","protected":false},"author":2,"featured_media":97445,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/media\/ZjgyZTFhNTUtZGUyZC00NTkzLWE0OTMtZDNkZTdkOGNlY2UwLTEwMjkyMTctMjAyNS0wOC0wOS1lbg==\/tiny\/Pomerantz-LLP.png","fifu_image_alt":"","footnotes":""},"categories":[208],"tags":[],"class_list":["post-97444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t